Variations in “rescuability” of immunoglobulin molecules from different forms of human lymphoma: implications for anti-idiotype vaccine development
- 1 October 2004
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 52 (1), 1-7
- https://doi.org/10.1016/j.critrevonc.2004.05.002
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Anti‐idiotype vaccinesBritish Journal of Haematology, 2003
- Immunotherapy for LymphomasInternational Journal of Hematology, 2003
- Incidence of potential glycosylation sites in immunoglobulin variable regions distinguishes between subsets of Burkitt's lymphoma and mucosa‐associated lymphoid tissue lymphomaBritish Journal of Haematology, 2003
- Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphomaBlood, 2002
- Role of anti-idiotype vaccines in the modern treatment of human follicular lymphomaExpert Review of Anticancer Therapy, 2001
- DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myelomaNature Medicine, 1998
- Induction of Immune Responses in Patients with B-Cell Lymphoma against the Surface-Immunoglobulin Idiotype Expressed by Their TumorsNew England Journal of Medicine, 1992
- Mouse × human heterohybridomas as fusion partners with human B cell tumorsJournal of Immunological Methods, 1986
- PROTECTIVE AND CELLULAR IMMUNE RESPONSES TO IDIOTYPIC DETERMINANTS ON CELLS FROM A SPONTANEOUS LYMPHOMA OF NZB/NZW F1 MICEThe Journal of Experimental Medicine, 1974
- Myeloma Proteins as Tumor-Specific Transplantation AntigensProceedings of the National Academy of Sciences, 1972